GEMZAR INJECTION 1gm vial contains Gemcitabine, an antineoplastic agent used primarily in the treatment of various cancers, including pancreatic, breast, and non-small cell lung cancer. This chemotherapy medication works by inhibiting the growth of cancer cells, thereby helping to control the spread of the disease.
The dosage of GEMZAR is determined by a healthcare professional based on the patient's condition, body surface area, and response to treatment. Typically, it is administered once a week for three weeks followed by a one-week rest period. Always follow the prescribed regimen provided by your healthcare provider.
Common side effects of GEMZAR may include:
Serious side effects are rare but can occur. It is important to contact a healthcare professional immediately if you experience severe symptoms such as difficulty breathing, swelling, or unusual bleeding.
GEMZAR is not recommended for use during pregnancy as it may harm the fetus. Consult your doctor for alternatives if you are pregnant or planning to become pregnant.
Yes, GEMZAR can be used in combination with other chemotherapy agents. Your healthcare provider will determine the best treatment plan based on your specific situation.
GEMZAR is administered intravenously by a healthcare professional. It is important to follow the treatment schedule as prescribed.